Leonardo Brunetti has been named the recipient of the 2026 European Society for Medical Oncology (ESMO) Artificial Intelligence Fellowship. The award, announced on OncoDaily, provides Brunetti with funding and mentorship to advance AI applications in cancer research. ESMO created the fellowship to accelerate the adoption of machine‑learning tools across oncology disciplines. Brunetti, an emerging researcher in computational oncology, will lead projects that aim to improve diagnosis, prognosis, and treatment planning through data‑driven models. The selection highlights the growing importance of AI expertise within the oncology community. By supporting this work, ESMO hopes to translate innovative algorithms into real‑world clinical impact.
This appointment not only recognizes Brunetti’s expertise but also illustrates ESMO’s commitment to nurturing AI talent. The fellowship will enable concrete projects that blend machine learning with clinical oncology.
What Changed?
- Leonardo Brunetti receives dedicated funding and mentorship to develop AI‑based oncology solutions.
- ESMO expands its AI Fellowship program, signaling a formalized pathway for AI talent in cancer research.
- The award spotlights AI as a core competency for future oncologists and researchers.
- Resources allocated to Brunetti will accelerate the creation of predictive models for diagnosis and treatment response.
- The fellowship sets a precedent for collaborative projects between AI specialists and clinical oncology teams.
A Milestone for AI‑Driven Oncology
Leonardo Brunetti’s selection for the 2026 ESMO Artificial Intelligence Fellowship underscores the accelerating integration of AI into oncology research and training, signaling a new era of data‑driven cancer care.